Plain-English translation of NCT05697991 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that aims to understand fatty liver disease—a condition where fat builds up in the liver—in people who have type 2 diabetes. Researchers want to learn more about how these two conditions are connected and what factors influence how the disease progresses, so they can develop better ways to prevent and treat it.
Fatty liver disease is very common but often goes undiagnosed, and it can lead to serious liver problems if not managed properly. Since people with type 2 diabetes are at higher risk for this condition, understanding the link between the two diseases is important for developing better prevention and treatment strategies.
You likely qualify if…
You likely don't qualify if…
This is an observational study, meaning researchers will follow participants and collect information about their health rather than test a new medication. You would likely share your medical history, undergo liver-related tests or scans, and possibly provide blood samples. The study is recruiting 1,000 people from Saudi Arabia to build a better understanding of how diabetes and fatty liver disease interact.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Saudi Arabia
King Fahad Medical City
Enrollment target
~1,000 participants
Started
March 2015
Primary completion
April 2030
Age range
18 Years – 60 Years
Last updated on clinicaltrials.gov in October 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Assim A Alfadda, MD
King Saud University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.